Georgetown University Medical Center ( Site 3534)

Washington D.C., District of Columbia 20007

0 studies enrolling now · 1 studies all time

What they study most

Carcinoma, Renal Cell

Studies at this site

• A Study of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Clear Cell Renal Cell Carcinoma Post Nephrectomy (MK-6482-022) — Running, not enrolling